{
    "code": "06020976",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06020976",
    "time": "2019-12-06 03:12:41",
    "許可證字號": "衛署醫器輸字第020976號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/04\/19",
    "發證日期": "99\/04\/19",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA00602097602",
    "中文品名": "“百而康”遞西微珠藥物傳遞栓塞系統",
    "英文品名": "“Biocompatibles” DC Bead Drug Delivery Embolisation System",
    "效能": "1.遞西微珠僅用於裝填doxorubicin HCl 以達成下列目的：  -在供應惡性腫瘤養分的增生血管內形成栓塞。  -局部持續對腫瘤釋放一定劑量的doxorubicin。2.遞西微珠可不與藥品合併使用在病灶血管內形成栓塞。適應症變更為：詳如中文仿單核定本(原101年5月16日及105年8月12日核定之仿單標籤核定本予以作廢)。",
    "醫器規格": "DC2V305 ( 300~500 μm )DC2V507 ( 500~700 μm )。DC2V103(100-300 μm)(標籤仿單變更，原99.5.6仿單核定本繳回作廢)。增加規格：DC Bead M1 (70-150μm) (DC2V001)。",
    "劑型": "",
    "包裝": "",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": "",
    "醫器主類別一": "E心臟血管用裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "620117J497  埃默高有限公司",
        "申請商地址": "新北市新店區北新路3段221號10樓",
        "主製造廠": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060209760001-108-05-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06020976&Seq=007&Type=9"
        },
        {
            "title": "060209760001-108-05-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06020976&Seq=003&Type=8"
        }
    ]
}